11 results
S1 |
Changing landscape of diagnosis and treatment of bladder cancer
Wun-Jae Kim
KMSID: 1088101 Investig Clin Urol. 2016;57(Suppl 1):S1-S3. Published online 2016 June 10 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S1 | |
S4 |
Active surveillance for nonmuscle invasive bladder cancer
Makito Miyake, Kiyohide Fujimoto, Yoshihiko Hirao
KMSID: 1088114 Investig Clin Urol. 2016;57(Suppl 1):S4-S13. Published online 2016 May 27 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S4 | |
S14 |
Dietary factors associated with bladder cancer
Chandrika Piyathilake
KMSID: 1088107 Investig Clin Urol. 2016;57(Suppl 1):S14-S25. Published online 2016 June 10 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S14 | |
S26 |
Treatment of bladder cancer in the elderly
Annette Erlich, Alexandre R. Zlotta
KMSID: 1088112 Investig Clin Urol. 2016;57(Suppl 1):S26-S35. Published online 2016 May 27 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S26 | |
S36 |
Open versus robotic cystectomy: Comparison of outcomes
Rachel B. Davis, Nicholas J. Farber, Alexandra L. Tabakin, Isaac Y. Kim, Sammy E. Elsamra
KMSID: 1088113 Investig Clin Urol. 2016;57(Suppl 1):S36-S43. Published online 2016 June 10 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S36 | |
S44 |
How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
Seok Joong Yun, Seon-Kyu Kim, Wun-Jae Kim
KMSID: 1088115 Investig Clin Urol. 2016;57(Suppl 1):S44-S51. Published online 2016 June 10 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S44 | |
S52 |
Aberrantly expressed microRNAs in the context of bladder tumorigenesis
Jong-Young Lee, Dong-Sung Ryu, Wun-Jae Kim, Seong-Jin Kim
KMSID: 1088116 Investig Clin Urol. 2016;57(Suppl 1):S52-S59. Published online 2016 June 10 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S52 | |
S60 |
The role of microRNAs in bladder cancer
Hideki Enokida, Hirofumi Yoshino, Ryosuke Matsushita, Masayuki Nakagawa
KMSID: 1088117 Investig Clin Urol. 2016;57(Suppl 1):S60-S76. Published online 2016 June 7 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S60 | |
S77 |
Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Yong-June Kim, Wun-Jae Kim
KMSID: 1088118 Investig Clin Urol. 2016;57(Suppl 1):S77-S88. Published online 2016 May 25 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S77 | |
S89 |
Autophagy and urothelial carcinoma of the bladder: A review
Thenappan Chandrasekar, Christopher P. Evans
KMSID: 1088119 Investig Clin Urol. 2016;57(Suppl 1):S89-S97. Published online 2016 June 10 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S89 | |
S98 |
Immune checkpoint blockade therapy for bladder cancer treatment
Jayoung Kim
KMSID: 1088120 Investig Clin Urol. 2016;57(Suppl 1):S98-S105. Published online 2016 May 26 DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S98 | |